Elastic fibers are essential components of the pulmonary extracellular matrix (ECM), composed primarily of elastin and associated microfibrillar proteins that assemble into highly organized, resilient networks1. In the lung, elastic fibers are arranged along alveolar septa and peribronchial structures, where they provide the elasticity and recoil required for normal respiratory mechanics1,2. As one of the most abundant structural ECM components in tissues such as the lung, aorta, and uterus, its integrity is critical for maintaining tissue compliance1,2. Disruption of elastic fiber organization has been observed in a range of pulmonary diseases, including fibrosis, emphysema, and chronic inflammatory conditions, where altered fiber architecture contributes to impaired lung function and mechanical properties2,3.
The lung matrisome has been recently characterized, revealing core ECM proteins such as collagens and laminins, together with matrisome-associated components including cytokines, ECM regulators, and ECM-affiliated proteins (e.g., integrin ligands, galectins)4,5. Beyond providing structural support, these components actively regulate tissue function and form specialized niches that support resident and migrating cells6,7. Notably, recent studies have highlighted that metabolic conditions such as obesity are associated with significant alterations in elastic fiber organization, linking systemic metabolic dysregulation to changes in lung ECM architecture and fibroblast function3. These findings underscore the importance of understanding elastic fiber remodeling as a dynamic and disease-relevant process.
Conventional assessment of elastic fibers often relies on qualitative histological evaluation, semi-quantitative scoring systems, or measurements of elastin abundance, which provide limited information regarding fiber organization, connectivity, and network complexity8,9. While these approaches are useful for detecting gross alterations in elastin content, they may not capture subtle architectural changes associated with tissue remodeling. Quantitative image-based analyses have the potential to overcome these limitations by enabling objective and reproducible characterization of elastic fiber networks and facilitating comparisons across experimental conditions and studies. To address this, the protocol described here enables integrated analysis of pulmonary ECM organization with a specific focus on elastic fiber architecture. In addition to established approaches for ECM characterization4,5, this workflow incorporates Elastica staining and a TWOMBLI-based10 image analysis pipeline optimized for lung tissue architecture. By combining Elastica staining with quantitative network analysis, this workflow extends beyond conventional histological assessment and enables detailed characterization of fiber abundance, fragmentation, spatial organization, and structural complexity. The protocol is particularly well-suited for studies investigating fibrosis, emphysema, obesity-associated lung remodeling, inflammatory lung diseases, aging, and other conditions characterized by extracellular matrix remodeling in the lung.